Family-based treatment: Where are we and where should we be going to improve recovery in child and adolescent eating disorders.


Journal

The International journal of eating disorders
ISSN: 1098-108X
Titre abrégé: Int J Eat Disord
Pays: United States
ID NLM: 8111226

Informations de publication

Date de publication:
04 2019
Historique:
received: 04 08 2018
revised: 15 10 2018
accepted: 20 10 2018
pubmed: 7 12 2018
medline: 8 10 2019
entrez: 7 12 2018
Statut: ppublish

Résumé

Family therapy has long been advocated as an effective intervention for eating disorders. A specific form of family therapy, one that utilizes family resources, has proven especially effective for adolescents with anorexia or bulimia nervosa (AN and BN). First developed in London, a behaviorally focused adaptation, called family-based treatment (FBT), has been manualized and systematically studied in six randomized clinical trials for adolescent AN and two for adolescent BN. This Commentary focuses on manualized FBT; what we know, what we do not know (yet), and what we hope for. We do know that efficacy data for FBT, especially adolescent AN, are quite robust, even though remission rates remain elusive for more than half of all cases. While preliminary, moderators of FBT for adolescent AN have been identified and could aid us in determining the most (or least) responsive patient groups. And weight gain (∼2.5kg) by week four has been confirmed as an early predictor of remission at end-of-treatment. What we do not know, yet, is whether specific adaptations to manualized FBT will confer improved remission rates. Finally, and in terms of what is hoped for, we highlight the promise of improved access, dissemination, and implementation of FBT.

Identifiants

pubmed: 30520532
doi: 10.1002/eat.22980
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

481-487

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

James Lock (J)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California.

Daniel Le Grange (D)

Department of Psychiatry and UCSF Weill Institute for Neurosciences, University of California, San Francisco, California.
Department of Psychiatry and Behavioral Neuroscience, Emeritus, The University of Chicago, Chicago, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH